2020
DOI: 10.1039/d0ob01912g
|View full text |Cite|
|
Sign up to set email alerts
|

Tyrosine bioconjugation – an emergent alternative

Abstract: Protein bioconjugation is an increasingly important field of research, with wide-ranging applications in areas such as therapeutics and biomaterials. Traditional cysteine and lysine bioconjugation strategies are widely used and have...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
66
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(66 citation statements)
references
References 60 publications
(108 reference statements)
0
66
0
Order By: Relevance
“…Promising approaches have recently been described to overcome the initial limitations of Lys 10,11 and Cys 12,13 modifications, and much effort is now dedicated to selectively target less exploited amino acids such as methionine, 14 tryptophan, 15,16 histidine 17,18 or tyrosine (Y). 19,20 Y usually occurs at low frequency in proteins (<5%) and is partially buried in the surface, offering unique opportunities for controlled labelling of the most reactive residues. 21,22 The phenol side chain of Y is neutral at physiological pH and experiences several biologically relevant post-translational modifications (phosphorylations, sulfations, nitrations, Oglycosylations, oxydations).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Promising approaches have recently been described to overcome the initial limitations of Lys 10,11 and Cys 12,13 modifications, and much effort is now dedicated to selectively target less exploited amino acids such as methionine, 14 tryptophan, 15,16 histidine 17,18 or tyrosine (Y). 19,20 Y usually occurs at low frequency in proteins (<5%) and is partially buried in the surface, offering unique opportunities for controlled labelling of the most reactive residues. 21,22 The phenol side chain of Y is neutral at physiological pH and experiences several biologically relevant post-translational modifications (phosphorylations, sulfations, nitrations, Oglycosylations, oxydations).…”
Section: Introductionmentioning
confidence: 99%
“…Promising approaches have recently been described to overcome the initial limitations of Lys 10,11 and Cys 12,13 modifications, and much effort is now dedicated to selectively target less exploited amino acids such as methionine, 14 tryptophan, 15,16 histidine 17,18 or tyrosine (Y). 19,20 …”
Section: Introductionmentioning
confidence: 99%
“…Promising approaches have been recently described to overcome the initial limitations of Lys 10,11 and Cys 12,13 modifications, and much efforts are now dedicated to selectively target less exploited amino acids such as methionine, 14 tryptophan, 15,16 histidine 17,18 or tyrosine (Y). 19,20 Y usually occur with low frequency in proteins (~3-4%) and are partially buried at the surface, offering unique opportunities for a controlled labelling of the most reactive residues. 21 The phenol side chain of Y is neutral at physiological pH and experience several post-translational modifications of biological relevance (phosphorylations, sulfations, nitrations, Oglycosylations, oxydations).…”
Section: Introductionmentioning
confidence: 99%
“…Building on the foundations of Pauly, [7] Inoue, and Landsteiner [8] as detailed by Higgins et al, [9.10] tyrosine (Tyr/Y) residues have piqued the interests of the bioconjugation community [11] . For excellent reviews of tyrosine conjugation methods for labelling of antibodies and proteins see Szijj et al [12] . and Dorta et al [13] .…”
Section: Introductionmentioning
confidence: 99%